$JNJ

AI Analysis

Generated on May 11, 2026

AI Score
71/ 100
Hold$JNJ

Johnson & Johnson

$JNJNYSEHealthcareMega-Cap

J&J is a diversified healthcare company with businesses in pharmaceuticals (Innovative Medicine) and medical devices (MedTech).

Market Cap
$360.0B
Revenue (TTM)
$85.2B
+5.0%
Net Income (TTM)
$14.3B
+8.0%
EPS (TTM)
$5.90
P/E Ratio
16.5
Dividend Yield
3.0%
52-Week Range
$140-$168
Beta
0.52
Dimension Scores
Fundamental
73
Technical
62
Sentiment
68
Risk / Reward
78
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
78strong
Growth
61moderate
Liquidity
86strong
Solvency
75strong
Efficiency
71strong

Valuation, technical analysis, investment thesis, risk assessment and more for $JNJ

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.